InvestorsHub Logo
Followers 9
Posts 1425
Boards Moderated 0
Alias Born 03/05/2006

Re: None

Wednesday, 03/09/2011 4:25:47 PM

Wednesday, March 09, 2011 4:25:47 PM

Post# of 424146
Leerink's biotech analyst holds an analyst/industry conference call
Biotech Analyst Schwartz discusses prospects for Amarin's AMR-101 in the treatment of mixed Dyslipidemia: previewing the ANCHOR Study on an Analyst/Industry conference call being held on March 10 at 11 am hosted by Leerink.

www.theflyonthewall.com/.../AMRNid1391681/AMRN-Leerinks-biotech-analyst-holds-an-analystindustry-conference-call
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News